Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (107 total)
-
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Webinaire
Date de la dernière mise à jour: 2020-11-18
Description: In this webinar, we will discuss current evidence surrounding clinical trials for COVID-19 therapeutics including ACTT1, ACTT2, and ACTT3, and describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for… -
Créateur: the GS-US-540-5773 Investigators
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-05
Description: We conducted a randomized, open-label, phase 3 trial involving hospitalized patients with confirmed SARS-CoV-2 infection, oxygen saturation of 94% or less while they were breathing ambient air, and radiologic evidence of pneumonia. -
Créateur: the ACTT-1 Study Group Members
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-05
Description: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.A response to this article was published:Dolin, Raphael,… -
Créateur: Stone, John H., Matthew J. Frigault, Naomi J. Serling-Boyd, Ana D. Fernandes, Liam Harvey, Andrea S. Foulkes, Nora K. Horick, Brian C. Healy, Ruta Shah, Ana Maria Bensaci, Ann E. Woolley, Sarah Nikiforow, Nina Lin, Manish Sagar, Harry Schrager, David…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-21
Description: The efficacy of interleukin-6 receptor blockade in hospitalized patients with coronavirus disease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear. -
Créateur: Arabi, Yaseen M., Ayed Y. Asiri, Abdullah M. Assiri, Hanan H. Balkhy, Ali Al Bshabshe, Majed Al Jeraisy, Yasser Mandourah, Mohamed H. A. Azzam, Abdulhadi M. Bin Eshaq, Sameera Al Johani, Shmeylan Al Harbi, Hani A. A. Jokhdar, Ahmad M. Deeb, Ziad A.…
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-07
Description: Whether combined treatment with recombinant interferon beta-1b and lopinavir–ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS) is unclear. -
Créateur: Horby, Peter W., Marion Mafham, Jennifer L. Bell, Louise Linsell, Natalie Staplin, Jonathan Emberson, Adrian Palfreeman, Jason Raw, Einas Elmahi, Benjamin Prudon, Christopher Green, Simon Carley, David Chadwick, Matthew Davies, Matthew P. Wise, J.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-05
Description: Lopinavir–ritonavir has been proposed as a treatment for COVID-19 on the basis of in vitro activity, preclinical studies, and observational studies. Here, we report the results of a randomised trial to assess whether lopinavir–ritonavir improves… -
Créateur: Furtado, Remo H. M., Otavio Berwanger, Henrique A. Fonseca, Thiago D. Corrêa, Leonardo R. Ferraz, Maura G. Lapa, Fernando G. Zampieri, Viviane C. Veiga, Luciano C. P. Azevedo, Regis G. Rosa, Renato D. Lopes, Alvaro Avezum, Airton L. O. Manoel, Felipe…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-09-08
Description: The efficacy and safety of azithromycin in the treatment of COVID-19 remain uncertain. We assessed whether adding azithromycin to standard of care, which included hydroxychloroquine, would improve clinical outcomes of patients admitted to the… -
Créateur: Boulware, David R., Matthew F. Pullen, Ananta S. Bangdiwala, Katelyn A. Pastick, Sarah M. Lofgren, Elizabeth C. Okafor, Caleb P. Skipper, Alanna A. Nascene, Melanie R. Nicol, Mahsa Abassi, Nicole W. Engen, Matthew P. Cheng, Derek LaBar, Sylvain A.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-08-06
Description: This reports on a randomized, double-blind, placebo-controlled trial across the United States and parts of Canada testing hydroxychloroquine as postexposure prophylaxis. -
Créateur: Normand, Sharon-Lise T.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-21
Description: In a platform trial, patients with a single disease are randomly assigned to a group of different therapies on the basis of a decision algorithm to determine whether any therapy has benefit. -
Créateur: The RECOVERY Collaborative Group.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-17
Description: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.